From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Anti-CD19 CAR-T cell therapy for acquired hemophilia A

Last Updated: Tuesday, May 13, 2025

A case report about a patient with immunosuppressive therapy–resistant acquired hemophilia A with intractable bleeding who achieved complete remission after autologous anti-CD19 CAR-T cell therapy.

Leukemia
Advertisement
News & Literature Highlights
Advertisement
Advertisement